Transforming growth factor-beta (TGF-β) is a member of a superfamily of pleiotropic proteins that regulate multiple cellular processes such as growth, development and differentiation. The intracellular effectors of TGF-beta signalling, the Smad proteins, are activated by receptors and translocate into the nucleus, where they regulate transcription. Although this pathway is inherently simple, combinatorial interactions in the heteromeric receptor and Smad complexes, receptor-interacting and Smad-interacting proteins, and cooperation with sequence-specific transcription factors allow substantial versatility and diversification of TGF-beta family responses. Other signalling pathways further regulate Smad activation and function.
In addition, TGF-beta receptors activate Smad-independent pathways that not only regulate Smad signalling, but also allow Smad-independent TGF-beta responses. Aberrant TGF-β signaling is associated with a variety of diseases, such as fibrosis, cardiovascular disease and cancer. Hence, the TGF-β signaling pathway is recognized as a potential drug target.
AN02 是一种 Curcumin (MS-M89652) 的衍生物,可抑制卵巢癌细胞的增殖、克隆形成、迁移和侵袭,剂量依赖性地上调 APC 表达,并通过 SMAD4 介导 CTLA-4 的降解,在小异种移植模型中显著抑制肿瘤生长并逆转肿瘤免疫抑制微环境,与 Ipilimumab (MS-I48399) 联合可增加疗效并抑制上皮-间质转化,因此可用于研究卵巢癌。
SRI-011381 (Standard) 是 SRI-011381 (MS-O98412) 的分析标准品,本产品用于研究及分析应用,而 SRI-011381 是一种具有口服生物活性的 TGF-β 信号通路激活剂,具有神经保护作用。
SRI-011381 hydrochloride 是一种具有口服生物活性、可透过血脑屏障并具有神经保护作用的 TGF-β 信号通路激活剂。
SRI-011381 (hydrochloride) (Standard) 是 SRI-011381 (hydrochloride) (MS-W42991) 的分析标准品,本产品用于研究及分析应用,而 SRI-011381 hydrochloride 是一种具有口服生物活性的 TGF-β 信号通路激活剂,具有神经保护作用。
SRI-011381-d5 是 SRI-011381 (MS-O98412) 的氘代物,而 SRI-011381 是一种具有口服生物活性的 TGF-β 信号通路激活剂,具有神经保护作用。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号